Cardium Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Cardium Therapeutics

Access the complete profile.

Cardium Therapeutics Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	11750 Sorrento Valley Road Suite 250 San Diego, CA 92121

Note: Revenues for privately held companies are statistical evaluations.


Cardium Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cardium Therapeutics's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Cardium Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Trademark Applications

Trademark applications show the products and services that Cardium Therapeutics is developing and marketing. Cardium Therapeutics doesn't have any recent trademark applications, indicating Cardium Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ACTIVATION THERAPEUTICS Pharmaceuticals for wound healing or orthopedic bone, ligament, tendon and cartilage regeneration; biologics, namely, pharmaceutical preparations for wound healing or orthopedic bone, ligament, tendon and cartilage regeneration; pharmaceutical products and preparations comprising DNA and protein for wound healing, orthopedic bone, ligament, tendon and cartilage regeneration; pharmaceutical hydrogels comprising a biologic, namely, collagen, viral vectors, or growth factors, for wound healing, orthopedic bone, ligament, tendon and cartilage regeneration	06/21/2013
BRAIN SECURE Dietary and nutritional supplements; Multi-vitamin preparations; Nutraceuticals for use as a dietary supplement; Vitamin and mineral supplements; Vitamin B preparations	05/30/2013
E-QUATION data analytics, medical data analytics	04/15/2013

See all trademarks and details in the Full Report.

Market Share of Cardium Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cardium Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Cardium Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MARAVAI INTERMEDIATE HOLDINGS	San Diego, CA	100
CUE HEALTH	San Diego, CA	95
AJINOMOTO ALTHEA	San Diego, CA	73
NEURELIS	San Diego, CA	20
ZENTALIS PHARMACEUTICALS	San Diego, CA	18
PLEXIUM	San Diego, CA	14

Other Companies at 11750 Sorrento Valley Road, San Diego CA

Company	Headquarters	Revenue ($ MM)
HEALTH SAVINGS ASSOCIATES INSURANCE SERVICES	San Diego, CA	100
PACIFIC CORNERSTONE ARCHITECTS	San Diego, CA	67
ZAVANTE THERAPEUTICS	San Diego, CA	0
KMCP ADVISORS II	San Diego, CA	0
CARMEL CAPITAL PARTNERS	San Diego, CA	0

Future Competition: Cardium Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Cardium Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)